Utama › Penyakit Paru-paru › Alabama
Kajian klinikal Penyakit Paru-paru di Alabama
13 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07489066A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 2
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245American Lung Association (ALA) Lung Health Cohort
- University Of Alabama, Birmingham
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 25 hingga 35 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Velocity Clinical Research, Mobile, Mobile
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07555483Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of Alabama, Birmingham
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 25 hingga 35 · Semua jantina · Dikemas kini 17 Jul 2026 · NCT06177717Housing, Environment, And Living Conditions for Transformed Health
- UAB Lung Health Center, Birmingham
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 89 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06925373Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT05297734Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT05975983Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.